EHP-inhibitors, such as Ehp-inhibitor, are specialized compounds used in biochemistry and pharmacology to target and inhibit the activity of the Ehp protein, which is involved in disease pathways, particularly the growth and proliferation of cancer cells. They are especially valuable in cancer research for breast and lung cancers, where they help block tumor growth by interfering with essential cellular processes. Studies have shown that inhibiting Ehp can slow or stop tumor progression. Additionally, EHP-inhibitors are being explored for treating other conditions related to abnormal cellular function, such as autoimmune diseases and neurological disorders. In drug development, they serve as key tools for designing therapies targeting abnormal enzyme or protein activity. Researchers utilize them to study biological mechanisms and identify therapeutic targets. However, research is still in the experimental stage, requiring further studies to confirm efficacy and safety for human use.